The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
there is a drug being made by a company I think in San Diego that is an antisense oligonucleotide so the drug disrupts the DNA um the process of of the the DNA making RNA to make APO little a so it interrupts the synthesis of the protein that turns an LDL into an LP little a and — the drug worked very well in phase two
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.